AAAAAA
Results:
1-16
|
Results: 16
Authors:
MACK PC
EDELMAN MJ
GANDARA DR
GUMERLOCK PH
Citation: Pc. Mack et al., UCN-01 SYNERGIZES WITH CISPLATIN (CDDP) IN NONSMALL CELL LUNG-CARCINOMA (NSCLC) CELL-LINES WITH WILD-TYPE AND MUTANT RB AND P53, Journal of investigative medicine, 46(1), 1998, pp. 126-126
Authors:
GUMERLOCK PH
MACK PC
LAW SM
EDELMAN MJ
GANDARA DR
Citation: Ph. Gumerlock et al., MOLECULAR MECHANISMS OF RESPONSE TO CELL-CYCLE MODULATING AGENTS IN NONSMALL CELL LUNG-CARCINOMA, Journal of investigative medicine, 46(1), 1998, pp. 169-169
Authors:
EDELMAN MJ
GANDARA DR
Citation: Mj. Edelman et Dr. Gandara, SMALL-CELL LUNG-CANCER - CURRENT STATUS OF NEW CHEMOTHERAPEUTIC-AGENTS, Critical reviews in oncology/hematology, 27(3), 1998, pp. 211-220
Authors:
GANDARA DR
ROILA F
WARR D
EDELMAN MJ
PEREZ EA
GRALLA RJ
Citation: Dr. Gandara et al., CONSENSUS PROPOSAL FOR 5HT(3) ANTAGONISTS IN THE PREVENTION OF ACUTE EMESIS RELATED TO HIGHLY EMETOGENIC CHEMOTHERAPY - DOSE, SCHEDULE, ANDROUTE OF ADMINISTRATION, Supportive care in cancer, 6(3), 1998, pp. 237-243
Authors:
LARA PN
GANDARA DR
WURZ GT
LAU D
UHRICH M
TURRELL C
RASCHKO J
EDELMAN MJ
SYNOLD T
DOROSHOW J
MUGGIA F
PEREZ EA
DEGREGORIO M
Citation: Pn. Lara et al., HIGH-DOSE TOREMIFENE AS A CISPLATIN MODULATOR IN METASTATIC NONSMALL CELL LUNG-CANCER - TARGETED PLASMA-LEVELS ARE ACHIEVABLE CLINICALLY, Cancer chemotherapy and pharmacology, 42(6), 1998, pp. 504-508
Authors:
EDELMAN MJ
MEYERS FJ
GRENNAN T
LAUDER J
DOROSHOW J
Citation: Mj. Edelman et al., PHASE-II TRIAL OF PYRAZINE DIAZOHYDROXIDE IN ANDROGEN-INDEPENDENT PROSTATE-CANCER, Investigational new drugs, 16(2), 1998, pp. 179-182
Authors:
EDELMAN MJ
GANDARA DR
PEREZ EA
LAU D
LAUDER I
TURRELL C
UHRICH M
MEYERS F
Citation: Mj. Edelman et al., PHASE-I TRIAL OF EDATREXATE PLUS CARBOPLATIN IN ADVANCED SOLID TUMORS- AMELIORATION OF DOSE-LIMITING MUCOSITIS BY ICE CHIP CRYOTHERAPY, Investigational new drugs, 16(1), 1998, pp. 69-75
Authors:
EDELMAN MJ
SIEGEL D
MEYERS F
Citation: Mj. Edelman et al., FOLLOW-UP TESTING AFTER CANCER-TREATMENT - IS IT INDICATED, Western journal of medicine, 168(6), 1998, pp. 528-529
Authors:
EDELMAN MJ
MEYERS FJ
SIEGEL D
Citation: Mj. Edelman et al., THE UTILITY OF FOLLOW-UP TESTING AFTER CURATIVE CANCER-THERAPY - A CRITICAL-REVIEW AND ECONOMIC-ANALYSIS, Journal of general internal medicine, 12(5), 1997, pp. 318-331
Authors:
EDELMAN MJ
ODONNELL RT
MEADOWS I
Citation: Mj. Edelman et al., TREATMENT OF REFRACTORY LARGE GRANULAR LYMPHOCYTIC-LEUKEMIA WITH 2-CHLORODEOXYADENOSINE, American journal of hematology, 54(4), 1997, pp. 329-331
Authors:
GANDARA DR
EDELMAN MJ
CROWLEY JJ
LAU DHM
LIVINGSTON RB
Citation: Dr. Gandara et al., PHASE-II TRIAL OF EDATREXATE PLUS CARBOPLATIN IN METASTATIC NON-SMALL-CELL LUNG-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Cancer chemotherapy and pharmacology, 41(1), 1997, pp. 75-78
Authors:
EDELMAN MJ
MEYERS FJ
HOUSTON J
LAUDER I
Citation: Mj. Edelman et al., PHASE-I TRIAL OF PACLITAXEL, CARBOPLATIN, AND METHOTREXATE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR AND LEUCOVORIN IN ADVANCED TRANSITIONAL-CELL CARCINOMA, Seminars in oncology, 24(5), 1997, pp. 68-71
Authors:
EDELMAN MJ
GANDARA DR
Citation: Mj. Edelman et Dr. Gandara, PROMISING NEW AGENTS IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER, Cancer chemotherapy and pharmacology, 37(5), 1996, pp. 385-393
Authors:
EDELMAN MJ
POTTER P
MAHAFFEY KG
FRINK R
LEIDICH RB
Citation: Mj. Edelman et al., THE POTENTIAL FOR REINTRODUCTION OF TUMOR-CELLS DURING INTRAOPERATIVEBLOOD SALVAGE - REDUCTION OF RISK WITH USE OF THE RC-400 LEUKOCYTE DEPLETION FILTER, Urology, 47(2), 1996, pp. 179-181
Authors:
EDELMAN MJ
GANDARA DR
ROACH M
BENFIELD JR
Citation: Mj. Edelman et al., MULTIMODALITY THERAPY IN STAGE-III NONSMALL CELL LUNG-CANCER (VOL 61,PG 1564, 1996), The Annals of thoracic surgery, 62(6), 1996, pp. 1892-1892
Authors:
EDELMAN MJ
GANDARA DR
ROACH M
BENFIELD JR
Citation: Mj. Edelman et al., MULTIMODALITY THERAPY IN STAGE-III NON-SMALL-CELL LUNG-CANCER, The Annals of thoracic surgery, 61(5), 1996, pp. 1564-1572
Risultati:
1-16
|